Relationship Between Clinical Control, Respiratory Symptoms and Quality of Life for Patients with COPD

References

• MiravitllesM, SorianoJB, García-RíoF, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64:863–868. doi:10.1136/thx.2009.11572519553233
   PubMed Web of Science ®Google Scholar
• KassebaumNJ, AroraM, BarberRM, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 19902015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1603–1658.27733283
   PubMed Web of Science ®Google Scholar
• AnzuetoA, MiravitllesM. Pathophysiology of dyspnea in COPD. Postgrad Med. 2017;129:366–374. doi:10.1080/00325481.2017.130119028277858
   PubMed Web of Science ®Google Scholar
• HananiaNA, O’DonnellDE. Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions. Int J Chron Obstruct Pulmon Dis. 2019;14:1127–1138. doi:10.2147/COPD.S18814131213793
   PubMed Web of Science ®Google Scholar
• NishimuraK, IzumiT, TsukinoM, OgaT. Dyspnea Is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434–1440. doi:10.1378/chest.121.5.143412006425
   PubMed Web of Science ®Google Scholar
• KesslerR, PartridgeMR, MiravitllesM, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011;37:264–272. doi:10.1183/09031936.0005111021115606
   PubMed Web of Science ®Google Scholar
• Espinosa de Los MonterosMJ, PeñaC, SotoHEJ, JareñoJ, MiravitllesM. Variability of respiratory symptoms in severe COPD. Arch Bronconeumol. 2012;48:3–7. doi:10.1016/j.arbres.2011.07.00421944843
   PubMed Web of Science ®Google Scholar
• LeidyNK, MurrayLT, MonzBU, et al. Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials. Respir Res. 2014;15:124. doi:10.1186/s12931-014-0124-z25287629
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJ, Alcázar-NavarreteB, MiravitllesM. The concept of control of COPD in clinical practice. Int J Chron Obstruct Pulmon Dis. 2014;9:1397–1405.25548521
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJ, Alcázar-NavarreteB, MiravitllesM. The concept of control in COPD: A new proposal for optimising therapy. Eur Respir J. 2014;44:1072–1075.25063243
   PubMed Web of Science ®Google Scholar
• NibberA, ChisholmA, Soler-CataluñaJJ, AlcazarB, PriceD, MiravitllesM. Validating the concept of COPD control: a real-world cohort study from the United Kingdom. COPD J Chronic Obstr Pulm Dis. 2017;14:504–512. doi:10.1080/15412555.2017.1350154
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJ, MarzoM, CatalanP, MirallesC, AlcazarB, MiravitllesM. Validation of clinical control in COPD as a new tool for optimizing treatment. Int J Chron Obstruct Pulmon Dis. 2018;13:3719–3731. doi:10.2147/COPD.S17814930532528
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJ, AlcázarB, MiravitllesM. Clinical control in COPD: a new therapeutic objective? Arch Bronconeumol. 2020;56:68–69. doi:10.1016/j.arbres.2019.06.00431301882
   PubMed Web of Science ®Google Scholar
• MiravitllesM, SliwinskiP, RheeCK, et al. Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD. Respir Med. 2018;136:8–14. doi:10.1016/j.rmed.2018.01.01929501251
   PubMed Web of Science ®Google Scholar
• Soler-CatalunaJJ, AlcazarB, MarzoM, et al. Validation of clinical control in COPD as a new tool for optimizing treatment. Chest. 2020;157:1138–1146.31759964
   PubMed Web of Science ®Google Scholar
• BarrechegurenM, KostikasK, MezziK, et al. COPD clinical control as a predictor of future exacerbations: concept validation in the SPARK study population. Thorax. 2020;75:351–353. doi:10.1136/thoraxjnl-2018-21275232041741
   PubMed Web of Science ®Google Scholar
• Grupo de Trabajo de GesEPOC. Guía de Práctica Clínica para el Diagnóstico y Tratamiento de Pacientes con Enfermedad Pulmonar Obstructiva Crónica (EPOC) – guía Española de la EPOC (GesEPOC). Versión 2017. Arch Bronconeumol. 2017;53(Suppl:1–64).
   Google Scholar
• VogelmeierCF, CrinerGJ, MartínezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Arch Bronconeumol. 2017;53:128–149. doi:10.1016/j.arbres.2017.02.00128274597
   PubMed Web of Science ®Google Scholar
• García-RíoF, CalleM, BurgosF, et al. Espirometría. Arch Bronconeumol. 2013;49:388–401. doi:10.1016/j.arbres.2013.04.00123726118
   PubMed Web of Science ®Google Scholar
• MillerMR. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. doi:10.1183/09031936.05.0003480516055882
   PubMed Web of Science ®Google Scholar
• JanssenMF, PickardAS, GolickiD, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Qual Life Res. 2013;22(7):1717–1727. doi:10.1007/s11136-012-0322-423184421
   PubMed Web of Science ®Google Scholar
• MiravitllesM, HuertaA, Fernández-VillarJA, et al. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual Life Outcomes. 2014;12:120. doi:10.1186/s12955-014-0120-525189786
   PubMed Web of Science ®Google Scholar
• JonesPW, BrusselleG, Dal NegroRW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38:29–35. doi:10.1183/09031936.0017721021565915
   PubMed Web of Science ®Google Scholar
• von ElmE, AltmanDG, EggerM, PocockSJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)statement: guidelines for reporting observational studies. Lancet 2007 Oct 20;370(9596):1453–7. PMID: 18064739
   Google Scholar
• TabbererM, LomasDA, BirkR, et al. Once-daily triple therapy in patients with COPD: patient-reported symptoms and quality of life. Adv Ther. 2018;35:56–71. doi:10.1007/s12325-017-0650-429313286
   PubMed Web of Science ®Google Scholar
• NishimuraK, OgaT, NakayasuK, OgasawaraM, HasegawaY, MitsumaS. How different are COPD-specific patient reported outcomes, health status, dyspnea and respiratory symptoms? An observational study in a working population. BMJ Open. 2019;9:e025132. doi:10.1136/bmjopen-2018-025132
   PubMed Web of Science ®Google Scholar
• BowlerR, AllinderM, JacobsonS, et al. Real-world use of rescue inhaler sensors, electronic symptom questionnaires and physical activity monitors in COPD. BMJ Open Respir Res. 2019;6:e000350. doi:10.1136/bmjresp-2018-000350
   PubMed Web of Science ®Google Scholar
• EsquinasC, RamonMA, NuñezA, et al. Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease. Qual Life Res. 2020;29:607–617. doi:10.1007/s11136-019-02340-431673922
   PubMed Web of Science ®Google Scholar
• MiravitllesM, SliwinskiP, RheeCK, et al. Respiratory Effectiveness Group (REG). Predictive value of control of COPD for risk of exacerbations: an international, prospective study. Respirology. 2020. doi:10.1111/resp.13811
   PubMed Web of Science ®Google Scholar